Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin releasing hormone agonist trigger

This paper describes the pathophysiology of ovarian hyperstimulation syndrome (OHSS), focusing specifically on the luteolytic benefits of the use of GnRH agonist to decrease OHSS and the possible rescue modalities available.

Like Comment

Authors

Human Mousavi Fatemi, M.D., Ph.D., Juan Garcia-Velasco, M.D., Ph.D.

Volume 103, Issue 4, Pages 870-873

Abstract

Ovarian hyperstimulation syndrome (OHSS) is one of the most serious, and potentially lethal, complications of controlled ovarian stimulation (COS). Induction of final oocyte maturation with a bolus of gonadotropin-releasing hormone (GnRH) agonist (GnRHa), instead of the criterion standard hCG, in patients undergoing ovarian stimulation significantly reduces the risk of OHSS and could be considered to be more physiologic. A bolus of GnRHa used in this context also acts as a luteolytic agent. From a clinical point of view, the most significant benefit of GnRHa trigger is its ability to induce quick and reversible luteolysis and thus reducing the risk of OHSS development. This paper describes the pathophysiology of OHSS, focusing specifically on the luteolytic benefits of using GnRHa to decrease OHSS and the possible corpus luteum rescue modalities available.

Read the full text at: http://www.fertstert.org/article/S0015-0282(15)00126-0/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.